Delivery Order SPE2DR25D1201-SPE2DR26FAJVE
Award Date 11/18/25
Potential Completion Date 11/19/25
Potential Value $10K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen (semaglutide injection), a diabetes and weight management medication. The contract, valued at $29,770.98, is a firm fixed-price delivery order with a completion date of October 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $9,140.61 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen (semaglutide), a GLP-1 receptor agonist medication used for weight management. This firm fixed-price delivery order, issued on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a competitive award with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,269.61 to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 mL pen (semaglutide injection), a GLP-1 receptor agonist medication used for weight management. The contract was awarded on September 2, 2025, with an ultimate completion date of September 3, 2025, and represents a firm fixed price, non-set-aside competitive procurement. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,875.17 to AmerisourceBergen Drug Corp for Zepbound 5 mg/0.5 mL pen (semaglutide injection), a GLP-1 receptor agonist used for weight management. This firm fixed price delivery order was competitively awarded without set-aside restrictions and is scheduled for completion by August 4, 2025. The contract was awarded on August 1, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania location, the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $5,760.08 to supply Zepbound 7.5mg/0.5ml (semaglutide injection), a GLP-1 receptor agonist medication used for weight management. The contract, issued on November 18, 2025, with completion by December 16, 2025, carries a firm fixed price and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order was competitively awarded without set-aside designation, reflecting the...
- The Defense Logistics Agency awarded a $21,121.26 delivery order to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 ml pen injections on July 29, 2025, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price delivery order represents a pediatric formulation of semaglutide, a glucagon-like peptide-1 receptor agonist used for chronic weight management. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,205.84 to AmerisourceBergen Drug Corp for Zepbound 10 mg/0.5 ml pen (semaglutide injection), a GLP-1 receptor agonist commonly prescribed for weight management. This firm fixed-price delivery order, awarded on July 25, 2025, with an ultimate completion date of July 28, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pen injections, with a contract ceiling value of $5,144.31. This is a firm fixed-price delivery order with an ultimate completion date of August 28, 2025, and represents a non-set-aside, competitively awarded procurement. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $3,962.03 delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 7.5 mg/0.5 mL pen injections on November 14, 2025, with completion targeted for November 17, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under the company's broader...
- The Defense Logistics Agency awarded a $3,229.56 delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Zepbound 10 mg/0.5 mL pen (semaglutide), a medication used for weight management. This firm fixed-price, non-set-aside delivery order will be completed by August 29, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical supplier to...